Caxton Associates (New York)’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,733	Closed	-$389K	–	545
2024 Q1	$389K	Buy	8,733 +6,831	+359%	+$305K	0.02%	348
2023 Q4	$73.8K	Sell	1,902 -8,022	-81%	-$311K	﹤0.01%	449
2023 Q3	$292K	Buy	9,924 +7,703	+347%	+$226K	0.04%	310
2023 Q2	$141K	Buy	+2,221	New	+$141K	0.02%	434